172 related articles for article (PubMed ID: 37086440)
21. High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study.
Divard G; Abbas R; Chenevier-Gobeaux C; Chanson N; Escoubet B; Chauveheid MP; Dossier A; Papo T; Dehoux M; Sacre K
Arthritis Res Ther; 2017 Jun; 19(1):132. PubMed ID: 28610589
[TBL] [Abstract][Full Text] [Related]
22. Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study.
Wolak T; Todosoui E; Szendro G; Bolotin A; Jonathan BS; Flusser D; Buskila D; Sukenik S; Abu-Shakra M
J Rheumatol; 2004 May; 31(5):909-14. PubMed ID: 15124249
[TBL] [Abstract][Full Text] [Related]
23. Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Croca SC; Griffin M; Farinha F; Isenberg DA; Nicolaides A; Rahman A
Rheumatology (Oxford); 2021 Sep; 60(9):4185-4198. PubMed ID: 33404639
[TBL] [Abstract][Full Text] [Related]
24. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Atherosclerosis in Sle Patients by Measuring Carotid Intima Media Thickness: A Cross Sectional Study.
Mukherjee R; Bhattacharya R; Naiya SB; Mondal SS; Lyngdoh L
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443433
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
27. Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype.
Ahmad Y; Shelmerdine J; Bodill H; Lunt M; Pattrick MG; Teh LS; Bernstein RM; Walker MG; Bruce IN
Rheumatology (Oxford); 2007 Jun; 46(6):983-8. PubMed ID: 17384179
[TBL] [Abstract][Full Text] [Related]
28. Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
Quevedo-Abeledo JC; Rúa-Figueroa Í; Sánchez-Pérez H; Naranjo A; de Armas-Rillo L; Tejera-Segura B; Lopez-Mejías R; González-Gay MÁ; Ferraz-Amaro I
Clin Exp Rheumatol; 2020; 38(5):917-924. PubMed ID: 31969232
[TBL] [Abstract][Full Text] [Related]
29. Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus.
Kao AH; Lertratanakul A; Elliott JR; Sattar A; Santelices L; Shaw P; Birru M; Avram Z; Thompson T; Sutton-Tyrrell K; Ramsey-Goldman R; Manzi S
Am J Cardiol; 2013 Oct; 112(7):1025-32. PubMed ID: 23827400
[TBL] [Abstract][Full Text] [Related]
30. Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.
Clancy R; El Bannoudi H; Rasmussen SE; Bornkamp N; Allen N; Dann R; Reynolds H; Buyon JP; Berger JS
J Thromb Haemost; 2019 Mar; 17(3):532-537. PubMed ID: 30638300
[TBL] [Abstract][Full Text] [Related]
31. Systemic lupus erythematosus: the influence of disease-related and classical risk factors on intima media thickness and prevalence of atherosclerotic plaques--a preliminary report. Beneficial effect of immunosuppressive treatment on carotid intima media thickness.
Kisiel B; Kruszewski R; Juszkiewicz A; Raczkiewicz A; Bachta A; Kłos K; Duda K; Saracyn M; Szymański K; Młozniak-Cieśla A; Grabowska-Jodkowska A; Olesińska M; Bogusławska-Walecka R; Niemczyk S; Płoski R; Tłustochowicz W
Acta Cardiol; 2015 Apr; 70(2):169-75. PubMed ID: 26148377
[TBL] [Abstract][Full Text] [Related]
32. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
Roman MJ; Crow MK; Lockshin MD; Devereux RB; Paget SA; Sammaritano L; Levine DM; Davis A; Salmon JE
Arthritis Rheum; 2007 Oct; 56(10):3412-9. PubMed ID: 17907140
[TBL] [Abstract][Full Text] [Related]
33. QRISK3 relation to carotid plaque is higer than that of score in patients with systemic lupus erythematosus.
Quevedo-Abeledo JC; Caceres L; Palazuelos C; Llorca J; González-Gay MÁ; Ferraz-Amaro I
Rheumatology (Oxford); 2022 Apr; 61(4):1408-1416. PubMed ID: 34240117
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus.
Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34921093
[TBL] [Abstract][Full Text] [Related]
35. Telomere length in patients with systemic lupus erythematosus and its associations with carotid plaque.
Skamra C; Romero-Diaz J; Sandhu A; Huang Q; Lee J; Pearce W; McPherson DD; Sutton-Tyrrell K; Pope R; Ramsey-Goldman R
Rheumatology (Oxford); 2013 Jun; 52(6):1101-8. PubMed ID: 23382361
[TBL] [Abstract][Full Text] [Related]
36. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis.
Wu GC; Liu HR; Leng RX; Li XP; Li XM; Pan HF; Ye DQ
Autoimmun Rev; 2016 Jan; 15(1):22-37. PubMed ID: 26455562
[TBL] [Abstract][Full Text] [Related]
37. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
[TBL] [Abstract][Full Text] [Related]
38. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
Maksimowicz-McKinnon K; Magder LS; Petri M
J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
[TBL] [Abstract][Full Text] [Related]
39. Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study.
Su L; Qi Z; Guan S; Wei L; Zhao Y
Front Immunol; 2022; 13():978910. PubMed ID: 36238309
[TBL] [Abstract][Full Text] [Related]
40. Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.
Ajeganova S; Gustafsson T; Jogestrand T; Frostegård J; Hafström I
Arthritis Res Ther; 2015 Mar; 17(1):84. PubMed ID: 25885788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
